FDA Accepts Vanda Pharmaceuticals, Inc. (VNDA) Iloperidone Resubmission and Sets New Action Date
7:41 PM Posted by MH
FDA Accepts Vanda Pharmaceuticals, Inc. (VNDA) Iloperidone Resubmission and Sets New Action Date
ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA has accepted Vanda's resubmission of the iloperidone New Drug Application (NDA).
Vanda's resubmission was a Complete Response to the not approvable action letter that the company received on July 25, 2008. The FDA has indicated that it has accepted the Complete Response for review and has set a new target action date of May 6, 2009.
May 6, 2009 at 8:06 PM
좋은하루되셨는지요
오늘 일이바빠서 블로그에못들어왔더니 이런 좋은 주식이 있네요. VNDA 에프터마켓에 10.50까지 갔네요. 사셨으면 추카드려요!